Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-20-011311
Filing Date
2020-05-19
Accepted
2020-05-19 17:29:39
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 dffn20200518_424b5.htm 424B5 544230
2 dffn20190514_s3img003.gif GRAPHIC 40946
3 dffn20190514_s3img004.gif GRAPHIC 41077
4 dffn20200518_424b5img001.jpg GRAPHIC 9279
5 logo1.jpg GRAPHIC 570608
6 s3img002.jpg GRAPHIC 43900
  Complete submission text file 0001437749-20-011311.txt   1513820
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-231541 | Film No.: 20894842
SIC: 2834 Pharmaceutical Preparations